p53 modulation of autophagy signaling in cancer therapies: perspectives mechanism and therapeutic targets

MA Rahman, MN Park, MDH Rahman… - Frontiers in cell and …, 2022 - frontiersin.org
The key tumor suppressor protein p53, additionally known as p53, represents an attractive
target for the development and management of anti-cancer therapies. p53 has been …

Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways

P Kubatka, A Mazurakova, M Samec, L Koklesova… - Epma Journal, 2021 - Springer
Inflammation is an essential pillar of the immune defense. On the other hand, chronic
inflammation is considered a hallmark of cancer initiation and progression. Chronic …

Interplay between stress and cancer—a focus on inflammation

S Vignjević Petrinović, MS Milošević… - Frontiers in …, 2023 - frontiersin.org
Stress is an integral part of life. While acute responses to stress are generally regarded as
beneficial in dealing with immediate threats, chronic exposure to threatening stimuli exerts …

p53/NF-kB balance in SARS-CoV-2 infection: From OMICs, genomics and pharmacogenomics insights to tailored therapeutic perspectives (COVIDomics)

D Milani, L Caruso, E Zauli, AM Al Owaifeer… - Frontiers in …, 2022 - frontiersin.org
SARS-CoV-2 infection affects different organs and tissues, including the upper and lower
airways, the lung, the gut, the olfactory system and the eye, which may represent one of the …

Nano-targeting vascular remodeling in cancer: recent developments and future directions

R Giordo, Z Wehbe, P Paliogiannis, AH Eid… - Seminars in Cancer …, 2022 - Elsevier
Tumor growth and progression are strictly dependent on the adequate blood supply of
oxygen and nutrients. The formation of new blood vessels and vascular networks is …

Mutant p53 in cell-cell interactions

S Pilley, TA Rodriguez, KH Vousden - Genes & development, 2021 - genesdev.cshlp.org
Abstract p53 is an important tumor suppressor, and the complexities of p53 function in
regulating cancer cell behaviour are well established. Many cancers lose or express mutant …

ATF6 supports lysosomal function in tumor cells to enable ER stress-activated macroautophagy and CMA: impact on mutant TP53 expression

R Benedetti, MA Romeo, A Arena… - Autophagy, 2024 - Taylor & Francis
The inhibition of the unfolded protein response (UPR), which usually protects cancer cells
from stress, may be exploited to potentiate the cytotoxic effect of drugs inducing ER stress …

Modulation of CD4 T cell response according to tumor cytokine microenvironment

T Accogli, M Bruchard, F Végran - Cancers, 2021 - mdpi.com
Simple Summary It is now accepted that CD4 T lymphocytes play an essential role in the anti-
tumor response. CD4 T lymphocytes can activate and regulate several aspects of innate and …

VPA and TSA interrupt the interplay between mutp53 and HSP70, leading to CHK1 and RAD51 down-regulation and sensitizing pancreatic cancer cells to AZD2461 …

MA Romeo, MS Gilardini Montani, R Benedetti… - International Journal of …, 2022 - mdpi.com
HDAC inhibitors (HDACi) represent promising anti-cancer treatments, as the acetylation of
histone and non-histone proteins is often dysregulated in cancer and contributes to cancer …

[HTML][HTML] Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53

R Benedetti, M Di Crosta, G D'Orazi, M Cirone - Biology, 2024 - mdpi.com
Simple Summary Post-translational modifications (PTMs) strongly influence the stability and
function of proteins. These modifications have been reported to affect wild-type (wt) p53 as …